This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Potassium permanganate
DrugBank Accession Number
DB13831
Background

Not Available

Type
Small Molecule
Groups
Experimental, Investigational
Structure
Thumb
Weight
Average: 158.032
Monoisotopic: 157.881409
Chemical Formula
KMnO4
Synonyms
  • Potassium permanganate
External IDs
  • NSC-146182

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Therapies
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Antiseptic SolutionSolution5.12 g/100gTopicalGrupo Salypro de Mexico, S.A. de C.V.2021-04-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Antiseptic SolutionPotassium permanganate (5.12 g/100g)SolutionTopicalGrupo Salypro de Mexico, S.A. de C.V.2021-04-01Not applicableUS flag

Categories

ATC Codes
V03AB18 — Potassium permanganateD08AX06 — Potassium permanganate
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as alkali metal permanganates. These are inorganic compounds in which the largest oxoanion is permanganate, and in which the heaviest atom not in an oxoanion is an alkali metal.
Kingdom
Inorganic compounds
Super Class
Mixed metal/non-metal compounds
Class
Alkali metal oxoanionic compounds
Sub Class
Alkali metal permanganates
Direct Parent
Alkali metal permanganates
Alternative Parents
Inorganic salts / Inorganic oxides
Substituents
Alkali metal permanganate / Inorganic oxide / Inorganic salt
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
00OT1QX5U4
CAS number
7722-64-7
InChI Key
VZJVWSHVAAUDKD-UHFFFAOYSA-N
InChI
InChI=1S/K.Mn.4O/q+1;;;;;-1
IUPAC Name
potassium manganesoylolate
SMILES
[K+].[O-][Mn](=O)(=O)=O

References

General References
Not Available
ChemSpider
22810
RxNav
8604
ChEMBL
CHEMBL3833305
Wikipedia
Potassium_permanganate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionHealthcare-associated Pneumonia (HCAP) / Nosocomial Pneumonia / Pneumonia, Aspiration / Ventilator Associated Bacterial Pneumonia1
3CompletedTreatmentSurgical Site Infections1
1RecruitingTreatmentCoronavirus Disease 2019 (COVID‑19) / Infections, Coronavirus1
Not AvailableActive Not RecruitingPreventionAbdominal Sepsis / Encephalitis / Injuries, Brain / Meningitis / Pancreatitis / Respiratory Distress Syndrome, Acute (ARDS) / Seizures / Trauma Injury1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionTopical5.12 g/100g
Powder
Tablet
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-2.3ChemAxon
pKa (Strongest Acidic)-7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area74.27 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity5.77 m3·mol-1ChemAxon
Polarizability6.08 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at June 23, 2017 20:49 / Updated at February 21, 2021 18:54